Conference abstractPublished 29 Aug 2018
The effects of 6-OHDA on iron metabolism in astrocytes are mediated by hypoxia-inducible factors
Qingdao University, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Disrupted iron homeostasis in the substantia nigra (SN) is involved in Parkinson's disease (PD). When loaded with iron neurons and microglia die, but astrocytes have a high iron tolerance and can proliferate in the same situation. Our previous studies have shown that in astrocytes, expression of divalent metal transporter 1 (DMT1) and iron export protein ferroportin1 (FPN1) are both upregulated after 6-hydroxydopamine (6-OHDA) treatment, but the mechanisms remain unclear. Hypoxiainducible factors (HIFs) are known to be important in regulating iron homeostasis. Binding of HIF-2α to the promoter region of the hypoxia response elements (HREs) of DMT1 and FPN1 increases their expression. However, as yet it is unclear if HIFs are involved in the regulation of DMT1 and FPN1 expression in astrocytes treated with 6-OHDA.Using western blots, we observed HIFs, DMT1 and FPN1 expressions in primary cultured astrocytes and SH-SY5Y neuron cell lines treated with 6-OHDA inhibitors of HIF-1α and HIF-2α, protein kinase C (PKC) inhibitor and PKC activator, radical scavenger and inducible NO synthase (iNOS) inhibitor. The ferrous iron traffic of astrocytes was determined by measuring the quenching or reversing of calcein fluorescence. In this study, we found that protein levels of HIF-1α and HIF-2α in astrocytes were significantly increased by treatment with 6-OHDA, whereas expression did not change in dopaminergic neurons. Furthermore, using inhibitors of HIF-1α and HIF-2α, we observed that an HIF-2α inhibitor markedly reduced the up-regulation of DMT1 and FPN1 by 6-OHDA and decreased ferrous iron influx and efflux. However, there was no effect following treatment of astrocytes with the HIF-1α inhibitor. We found that PMA activated HIF-2α, leading to increased expression of DMT1 and FPN1. Activation of HIF-2α by PMA and 6-OHDA was blocked by Bisl preventing downstream activation of DMT1 and FPN1. Likewise, N-acetyll- cysteine (NAC) or Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME) were found to block HIF-2α activation by 6-OHDA. Our data indicate that HIF-2α, but not HIF-1α, regulates expression of DMT1 and FPN1 in astrocytes. Furthermore we conclude that PKC pathway, reactive oxygen species (ROS) and reactive nitrogen species (RNS) were involved in HIF-2α activation.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectDiabetes & Endocrinology
- SubjectSocial Sciences & Humanities
- BylineArticles whose byline prints “Jun Wang”